EFFICACY OF NARROWBAND ULTRAVIOLET B 311 NM PLUS AN INHIBITOR OF PHOSPHODIESTERASE 4 (PDE4) COMBINED THERAPY IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS

Olga Yu. Olisova; E. V Grekova; D. A Svistunova

doi:10.17816/dv42951

Russian Journal of Skin and Venereal Diseases ›› 2019, Vol. 22 ›› Issue (5-6) : 149 -155. DOI: 10.17816/dv42951

Articles

research-article

EFFICACY OF NARROWBAND ULTRAVIOLET B 311 NM PLUS AN INHIBITOR OF PHOSPHODIESTERASE 4 (PDE4) COMBINED THERAPY IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS

Author information +

History +

PDF

Abstract

Objective. to determine the effectiveness and tolerability of narrowband ultraviolet (UV) B (311 nm) plus an inhibitor of phosphodiesterase 4 (PDE4) combined therapy in patients with moderate to severe plaque psoriasis. Material and methods. the first group consisted of 30 patients (18 women and 12 men) who were treated with UVB 311 nm and inhibitor of phosphodiesterase 4 (PDE4). The second (control) group was treated with UVB 311 nm and methotrexate (n = 30; 15 women and 15 men). The study participants were aged 32 to 67 (43.8 ± 4.34). Results. it was determined greater efficiency (PASI 100 43.3% of patients and PASI 90 46.7%) of the treatment plaque moderate to severe psoriasis patients with UVB 311 nm plus an inhibitor of PDE4 compared to UVB 311 nm plus methotrexate (PASI 100 10% of patients and PASI 90 40%). The treatment was well-tolerated. The side effects in both groups were mild, did not require the cancellation of the prescribed treatment regimen, and were often stopped on their own or with minimal corrective therapy.

Keywords

plaque psoriasis / moderate to severe severity / UVB 311 nm / inhibitor of PDE4

Cite this article

Download citation ▾

Olga Yu. Olisova, E. V Grekova, D. A Svistunova. EFFICACY OF NARROWBAND ULTRAVIOLET B 311 NM PLUS AN INHIBITOR OF PHOSPHODIESTERASE 4 (PDE4) COMBINED THERAPY IN PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS. Russian Journal of Skin and Venereal Diseases, 2019, 22(5-6): 149-155 DOI:10.17816/dv42951

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Асхаков М.С., Чеботарев В.В. Псориаз современное представление о дерматозе. Медицинский вестник Северного Кавказа. 2017; (2): 225-9.

[2]	Forchhammer S., Ghoreschi K. Update on the treatment of psoriasis and psoriatic arthritis - role of apremilast. Psoriasis: Targets and Therapy. (Auckl). 2015; 5: 117-24.

[3]	AbuHilal M., Walsh S., Shear N. Use of apremilast in combination with other therapies for treatment of chronic plaque psoriasis: a retrospective study. J. Cutan. Med. Surg. 2016; 20(4): 313-6.

[4]	Asawanonda P., Nateetongrungsak Y. Methotrexate plus narrowband UVB phototherapy versus narrowband UVB phototherapy alone in the treatment of plaque-type psoriasis: a randomized, placebo-controlled study. J. Am. Acad. Dermatol. 2006; 54(6): 1013-8.

[5]	Bagel J., Nelson E., Keegan B.R. Apremilast and narrowband ultraviolet B combination therapy for treating moderate-to-severe plaque psoriasis. J. Drugs Dermatol. 2017; 16(10): 957-62.